• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型梗阻性心肌病有症状患者的性别差异 - 是否需要新的定义?

Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?

机构信息

Comprehensive Heart Failure Center (CHFC), University Clinic, Wuerzburg, Germany; Medizinische Klinik 1, Leopoldina-Krankenhaus, Schweinfurt, Germany.

Medizinische Klinik 1, Leopoldina-Krankenhaus, Schweinfurt, Germany.

出版信息

Int J Cardiol. 2021 Apr 1;328:117-121. doi: 10.1016/j.ijcard.2020.12.039. Epub 2020 Dec 31.

DOI:10.1016/j.ijcard.2020.12.039
PMID:33359283
Abstract

INTRODUCTION

Sex-related differences in diagnosis and treatment of hypertrophic obstructive cardiomyopathy (HOCM) are still unclear. Therefore, we analyzed baseline characteristics of symptomatic patients with indication for alcohol septal ablation (PTSMA) with respect to gender.

METHODS AND RESULTS

Between 05/2000 and 06/2017 indication for PTSMA was seen in 1014 patients (420 (41.4%) women and 594 (58.6%) men). Women were older (61.4 ± 15.0 vs. 51.8 ± 13.6 years; p < 0.00001) and suffered more often from dyspnea NYHA III/IV (81.4% vs. 67.7%; p < 0.001), whereas angina pectoris and syncopes were comparable. Echocardiographic gradients were comparable in women (66.4 ± 39.1 mmHg at rest and 106.5 ± 46.6 mmHg at Valsalva) and men (62.7 ± 38.8 mmHg at rest and 103.7 ± 42.7 mmHg at Valsalva). Women had smaller absolute diameter of the left atrium (LA) (44.4 ± 6.9 vs. 47.2 ± 6.5 mm; p < 0.0001), septal thickness (IVS) (20.5 ± 4.1 vs. 21.4 ± 4.5 mm; p < 0.01), and left ventricular posterior wall thickness (LVPW) (12.7 ± 2.8 vs. 13.6 ± 2.9 mm; p < 0.0001). But, indexed for BSA the relationship reversed in LA (25.2 ± 4.3 mm/m in women vs. 23.1 ± 3.4 mm/m), IVS (11.7 ± 2.7 mm/m in women vs. 10.6 ± 2.5 mm/m) and LVPW (7.3 ± 1.7 mm/m in women vs. 6.7 ± 1.6 mm/m), p < 0.00001 each.

CONCLUSION

Women with HOCM and indication for PTSMA are older and more symptomatic with advanced disease progression. Reconsideration of disease definition and awareness maybe necessary in order to avoid delayed diagnosis and treatment of HOCM in women.

摘要

简介

在肥厚型梗阻性心肌病(HOCM)的诊断和治疗方面,性别相关的差异仍不清楚。因此,我们分析了有酒精室间隔消融术(PTSMA)适应证的症状性患者的基线特征,分析了其与性别相关的差异。

方法和结果

2000 年 5 月至 2017 年 6 月期间,共有 1014 例患者(420 例女性和 594 例男性)有 PTSMA 适应证。女性年龄更大(61.4 ± 15.0 岁 vs. 51.8 ± 13.6 岁;p < 0.00001),更常出现 NYHA III/IV 级呼吸困难(81.4% vs. 67.7%;p < 0.001),而心绞痛和晕厥的发生率相似。女性和男性的超声心动图梯度相似(静息时分别为 66.4 ± 39.1mmHg 和 62.7 ± 38.8mmHg,valsalva 时分别为 106.5 ± 46.6mmHg 和 103.7 ± 42.7mmHg)。女性的左心房(LA)绝对直径(44.4 ± 6.9mm vs. 47.2 ± 6.5mm;p < 0.0001)、室间隔厚度(IVS)(20.5 ± 4.1mm vs. 21.4 ± 4.5mm;p < 0.01)和左心室后壁厚度(LVPW)(12.7 ± 2.8mm vs. 13.6 ± 2.9mm;p < 0.0001)更小。但经体表面积校正后,LA(女性 25.2 ± 4.3mm/m vs. 男性 23.1 ± 3.4mm/m)、IVS(女性 11.7 ± 2.7mm/m vs. 男性 10.6 ± 2.5mm/m)和 LVPW(女性 7.3 ± 1.7mm/m vs. 男性 6.7 ± 1.6mm/m)的关系发生逆转,p 值均<0.0001。

结论

有 PTSMA 适应证的 HOCM 女性年龄更大,症状更严重,疾病进展更严重。为了避免女性 HOCM 的诊断和治疗延迟,可能需要重新考虑疾病的定义和认识。

相似文献

1
Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?肥厚型梗阻性心肌病有症状患者的性别差异 - 是否需要新的定义?
Int J Cardiol. 2021 Apr 1;328:117-121. doi: 10.1016/j.ijcard.2020.12.039. Epub 2020 Dec 31.
2
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病:18例患者的急性结果及三年无创随访
Can J Cardiol. 2004 Jun;20(8):779-82.
3
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].[经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病]
Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2.
4
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].[经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:66例患者的急性结果及心肌对比超声心动图分析]
Z Kardiol. 1998 Mar;87(3):191-201. doi: 10.1007/s003920050171.
5
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:来自单一中心119例患者的中国经验
Int J Cardiol. 2004 Feb;93(2-3):197-202. doi: 10.1016/j.ijcard.2003.03.005.
6
[Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].肥厚性梗阻性心肌病的非药物治疗——经皮腔内室间隔心肌消融术治疗结果与双腔心脏起搏治疗结果的对比
Vnitr Lek. 2006 Apr;52(4):313-20.
7
[Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].肥厚性梗阻性心肌病患者经皮腔内室间隔消融术后的长期预后
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):294-301. doi: 10.3760/cma.j.cn112148-20190603-00312.
8
Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内室间隔心肌消融术后左心室的早期重塑及心肌性能改善
Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9.
9
[Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].经胸超声心动图引导下经皮心肌间隔射频消融术治疗梗阻性肥厚型心肌病患者的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Apr 24;47(4):284-290. doi: 10.3760/cma.j.issn.0253-3758.2019.04.005.
10
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.酒精间隔消融术治疗肥厚型梗阻性心肌病:已发表研究的系统评价
J Interv Cardiol. 2006 Aug;19(4):319-27. doi: 10.1111/j.1540-8183.2006.00153.x.

引用本文的文献

1
Hearts apart: sex differences in cardiac remodeling in health and disease.心有别属:健康与疾病中心脏重构的性别差异。
J Clin Invest. 2024 Jul 1;134(13):e180074. doi: 10.1172/JCI180074.
2
A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy.肥厚型心肌病临床结局性别差异的系统评价与荟萃分析。
Front Cardiovasc Med. 2023 Dec 5;10:1252266. doi: 10.3389/fcvm.2023.1252266. eCollection 2023.
3
Sex-Related Differences in Genetic Cardiomyopathies.性相关遗传性心肌病的差异。
J Am Heart Assoc. 2022 May 3;11(9):e024947. doi: 10.1161/JAHA.121.024947. Epub 2022 Apr 26.
4
Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.年龄相关的性别差异对肥厚型心肌病患者结局的影响。
PLoS One. 2022 Feb 25;17(2):e0264580. doi: 10.1371/journal.pone.0264580. eCollection 2022.
5
Age-related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.酒精室间隔消融术治疗肥厚型梗阻性心肌病的年龄相关生存率。
ESC Heart Fail. 2022 Feb;9(1):327-336. doi: 10.1002/ehf2.13750. Epub 2021 Dec 13.